Mr Leach was also appointed as a director to fill the vacancy created by the passing of Zarko Kraljevic in March 2008. Mr Kay will remain the non-executive chairman of the board.
Before joining the Integrated BioPharma in 2006, Mr Leach was a general partner in the Stone Pine Companies. Mr Leach’s experience includes considerable complex restructuring, repositioning and turn-around activities for Stone Pine portfolio companies.
Mr Leach said: “I am very excited about the opportunities for Integrated BioPharma. Now that its biotech business has been spun-off and its pharmaceutical businesses are moving toward sale, I will be restructuring the company and its expenses to efficiently re-assert its expertise and success in the nutraceutical field.”